9 September 2019

Important progress made in research on treatment for MS and Alzheimer’s

For the first time, in experimental animal models for MS, researchers at Maastricht University (UM) and Hasselt University (UHasselt) have succeeded in restoring the substance myelin, which is degraded by the disease. The restorative effect is produced by supressing the action of specific proteins that are crucial to the reduction in myelin production. In Maastricht, scientists are studying whether the suppression of the same enzymes can also improve cognition in Alzheimer’s patients. To achieve this, the researchers are looking at a drug that has already been on the market for a long time, but which is currently prescribed to people with serious COPD.